|
US3686398A
(en)
|
1970-07-20 |
1972-08-22 |
Chevron Res |
10,9-boroxarophenanthrene as fungicides
|
|
US4194047A
(en)
|
1975-11-21 |
1980-03-18 |
Merck & Co., Inc. |
Substituted N-methylene derivatives of thienamycin
|
|
US4260543A
(en)
|
1978-07-03 |
1981-04-07 |
Merck & Co., Inc. |
Crystalline N-formimidoyl thienamycin
|
|
US4409214A
(en)
|
1979-11-19 |
1983-10-11 |
Fujisawa Pharmaceutical, Co., Ltd. |
7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
|
|
US4353807A
(en)
|
1981-03-24 |
1982-10-12 |
Mobil Oil Corporation |
Lubricants and fuels containing boroxarophenanthrene compounds
|
|
FR2573070B1
(fr)
|
1984-11-13 |
1987-01-30 |
Rhone Poulenc Sante |
Procede de preparation de composes carbonyles
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US4822786A
(en)
|
1986-07-01 |
1989-04-18 |
Kaken Pharmaceutical Co., Ltd. |
Cephalosporin compounds, and antibacterial agents
|
|
ZA893284B
(en)
|
1988-05-04 |
1990-03-28 |
Igen Inc |
Peptide analogs and their use as haptens to elicit catalytic antibodies
|
|
US5442100A
(en)
|
1992-08-14 |
1995-08-15 |
The Procter & Gamble Company |
β-aminoalkyl and β-N-peptidylaminoalkyl boronic acids
|
|
US5888998A
(en)
|
1997-04-24 |
1999-03-30 |
Synphar Laboratories, Inc. |
2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
|
|
US6184363B1
(en)
|
1997-06-13 |
2001-02-06 |
Northwestern University |
Inhibitors of β-lactamases and uses therefor
|
|
JP2002504122A
(ja)
|
1997-06-13 |
2002-02-05 |
ノースウエスタン ユニバーシティー |
ベータラクタマーゼ阻害剤及びその使用方法
|
|
WO2000035905A1
(en)
|
1998-12-16 |
2000-06-22 |
Northwestern University |
INHIBITORS OF β-LACTAMASES AND USES THEREFOR
|
|
AU3124300A
(en)
|
1998-12-16 |
2000-07-03 |
Northwestern University |
Inhibitors of beta-lactamases and uses therefor
|
|
IL148818A0
(en)
|
1999-09-25 |
2002-09-12 |
Smithkline Beecham Plc |
Piperazine derivatives as 5-ht1b
|
|
CA2388077A1
(en)
|
1999-10-28 |
2001-05-03 |
James M. Balkovec |
Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
|
|
WO2002022137A1
(en)
|
2000-09-12 |
2002-03-21 |
Shoichet Brian K |
β-LACTAM ANALOGS AND USES THEREFOR
|
|
AU1261402A
(en)
|
2000-09-14 |
2002-03-26 |
Naeja Pharmaceutical Inc |
3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents
|
|
AU2002243508A1
(en)
|
2001-01-10 |
2002-07-24 |
Bristol-Myers Squibb Company Patent Department |
Alpha-aminoboronic acids prepared by novel synthetic methods
|
|
DE10118698A1
(de)
|
2001-04-17 |
2002-11-07 |
Jerini Ag |
Verfahren zur Immobilisierung und damit hergestellte Anordnungen von Verbindungen auf einer planaren Oberfläche
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
FR2835186B1
(fr)
|
2002-01-28 |
2006-10-20 |
Aventis Pharma Sa |
Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
|
|
JP2003229277A
(ja)
|
2002-02-04 |
2003-08-15 |
Matsushita Electric Ind Co Ltd |
発光素子材料およびそれを用いた発光素子並びに装置
|
|
AUPS065102A0
(en)
|
2002-02-20 |
2002-03-14 |
Unisearch Limited |
Fluorous acetalation
|
|
EP1550657A4
(en)
|
2002-09-11 |
2009-12-30 |
Kureha Corp |
AMINO COMPOUNDS AND THEIR USE
|
|
EP3412696A1
(en)
|
2002-10-30 |
2018-12-12 |
Sumitomo Chemical Company, Limited |
High-molecular compounds and polymer light emitting devices made by using the same
|
|
US7439253B2
(en)
|
2002-12-06 |
2008-10-21 |
Novexel |
Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
|
|
US7271186B1
(en)
|
2002-12-09 |
2007-09-18 |
Northwestern University |
Nanomolar β-lactamase inhibitors
|
|
MXPA05006798A
(es)
|
2002-12-20 |
2006-03-09 |
Migenix Corp |
Ligandos de adenina nucleotido translocasa (ant) y composiciones y metodos relacionados a estos.
|
|
TW200418791A
(en)
|
2003-01-23 |
2004-10-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions for inhibiting proteasome
|
|
JP4233365B2
(ja)
|
2003-03-25 |
2009-03-04 |
三井化学株式会社 |
アザジオール錯体化合物、及び該化合物を用いる光記録媒体
|
|
WO2005033090A1
(ja)
|
2003-10-06 |
2005-04-14 |
Sumitomo Chemical Company, Limited |
芳香族化合物
|
|
ES2288270T3
(es)
|
2003-10-10 |
2008-01-01 |
Pfizer Products Incorporated |
2h-(1,2,4)triazolo(4,3-a)pirazinas sustituidas como inhibidores de gsk-3.
|
|
BRPI0416444B8
(pt)
|
2003-11-12 |
2021-05-25 |
Chiesi Farm Spa |
composto de ácido borônico heterocíclico, composição farmacêutica, e, combinação farmacêutica compreendendo o mesmo
|
|
TW200600494A
(en)
|
2004-03-08 |
2006-01-01 |
Chugai Pharmaceutical Co Ltd |
Bisphenyl compounds useful as vitamin d3 receptor agonists
|
|
US20060019116A1
(en)
|
2004-07-22 |
2006-01-26 |
Eastman Kodak Company |
White electroluminescent device with anthracene derivative host
|
|
TW200618820A
(en)
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
|
US20060178357A1
(en)
|
2005-02-10 |
2006-08-10 |
Buynak John D |
Chphalosporin-derived mercaptans as inhibitors of serine and metallo-beta-lactamases
|
|
KR101337045B1
(ko)
|
2005-02-16 |
2013-12-05 |
아나코르 파마슈티칼스 인코포레이티드 |
보론함유 소분자
|
|
CA2680693A1
(en)
|
2005-02-22 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Preparation of rosuvastatin
|
|
US9184428B2
(en)
|
2005-03-15 |
2015-11-10 |
Uchicago Argonne Llc |
Non-aqueous electrolytes for lithium ion batteries
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
TW200734311A
(en)
|
2005-11-21 |
2007-09-16 |
Astrazeneca Ab |
New compounds
|
|
DK2484680T3
(da)
|
2005-12-07 |
2013-09-08 |
Basilea Pharmaceutica Ag |
Nyttige kombinationer af monolactam-antibiotika med beta-lactamase-inhibitorer
|
|
KR20150013941A
(ko)
|
2006-02-16 |
2015-02-05 |
아나코르 파마슈티칼스 인코포레이티드 |
항염증제로서 보론함유 소분자
|
|
WO2008039420A2
(en)
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Novel inhibitors of beta-lactamase
|
|
BRPI0809147A2
(pt)
|
2007-03-23 |
2014-08-26 |
Basilea Pharmaceutica Ag |
Medicamentos combinados para tratamento de infecções bacterianas
|
|
GB0719366D0
(en)
|
2007-10-03 |
2007-11-14 |
Smithkline Beecham Corp |
Compounds
|
|
US20100120715A1
(en)
|
2007-11-13 |
2010-05-13 |
Burns Christopher J |
Beta-lactamase inhibitors
|
|
AU2008321443A1
(en)
|
2007-11-13 |
2009-05-22 |
Novartis Ag |
Beta-lactamase inhibitors
|
|
ME02089B
(me)
|
2008-01-18 |
2014-04-30 |
Merck Sharp & Dohme |
Inhibitori beta-laktamaze
|
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
WO2009140309A2
(en)
|
2008-05-12 |
2009-11-19 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
EP2273882A4
(en)
|
2008-05-13 |
2011-07-13 |
Poniard Pharmaceuticals Inc |
BIOACTIVE COMPOUNDS FOR THE TREATMENT OF CANCER AND NEURODEEGENERATIVE DISEASES
|
|
WO2010075286A1
(en)
|
2008-12-24 |
2010-07-01 |
University Of Washington |
MOLECULAR ACTIVATORS OF THE Wnt/β-CATENIN PATHWAY
|
|
WO2010097675A1
(en)
|
2009-02-27 |
2010-09-02 |
Dhanuka Laboratories Ltd. |
An improved preparation process for cefpodoxime proxetil
|
|
EP2406233B1
(en)
|
2009-03-09 |
2013-11-13 |
Bristol-Myers Squibb Company |
Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
|
|
AR076667A1
(es)
|
2009-05-12 |
2011-06-29 |
Novartis Int Pharm Ltd |
Inhibidores de beta-lactamasa
|
|
JP2012529511A
(ja)
|
2009-06-08 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
|
RU2012107163A
(ru)
|
2009-07-28 |
2013-09-10 |
Анакор Фармасьютикалз, Инк. |
Тризамещенные борсодержащие молекулы
|
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
|
CN102892291A
(zh)
|
2010-03-31 |
2013-01-23 |
米伦纽姆医药公司 |
1-氨基-2-环丙基乙硼酸衍生物
|
|
US20110288063A1
(en)
|
2010-05-19 |
2011-11-24 |
Naeja Pharmaceutical Inc. |
Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
|
|
US8822516B2
(en)
|
2010-06-10 |
2014-09-02 |
Technion Research & Development Foundation Limited |
Process for the preparation of iodides
|
|
CN103180328B
(zh)
|
2010-08-10 |
2016-10-26 |
莱姆派克斯制药公司 |
环硼酸酯衍生物及其治疗用途
|
|
JP5909239B2
(ja)
|
2010-10-26 |
2016-04-26 |
マーズ インコーポレイテッド |
アルギナーゼ阻害剤としてのボロネート
|
|
AU2011329486A1
(en)
|
2010-11-18 |
2013-04-18 |
Glaxo Group Limited |
Compounds
|
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
|
EP2508506A1
(en)
|
2011-04-08 |
2012-10-10 |
LEK Pharmaceuticals d.d. |
Preparation of sitagliptin intermediates
|
|
CN102320960A
(zh)
|
2011-08-02 |
2012-01-18 |
安徽东健化工科技有限公司 |
一种6-氟水杨酸的制备方法
|
|
US9012491B2
(en)
|
2011-08-31 |
2015-04-21 |
Rempex Pharmaceuticals, Inc. |
Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2013053372A1
(en)
|
2011-10-13 |
2013-04-18 |
Therabor Pharmaceuticals |
Boronic acid inhibitors of beta-lactamases
|
|
WO2013056163A1
(en)
|
2011-10-14 |
2013-04-18 |
The Regents Of The University Of California |
Beta-lactamase inhibitors
|
|
CN104321060B
(zh)
|
2011-12-22 |
2018-08-07 |
阿雷斯贸易股份有限公司 |
α-氨基硼酸衍生物，选择性免疫蛋白酶体抑制剂
|
|
CA2862710A1
(en)
|
2012-01-09 |
2013-07-18 |
University Of Tromso |
Therapeutic boron-containing compounds
|
|
EP2615080A1
(en)
|
2012-01-12 |
2013-07-17 |
LEK Pharmaceuticals d.d. |
Preparation of Optically Pure ß-Amino Acid Type Active Pharmaceutical Ingredients and Intermediates thereof
|
|
EP2814483A2
(en)
|
2012-02-15 |
2014-12-24 |
Rempex Pharmaceuticals, Inc. |
Methods of treating bacterial infections
|
|
US9156858B2
(en)
|
2012-05-23 |
2015-10-13 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US10561675B2
(en)
|
2012-06-06 |
2020-02-18 |
Rempex Pharmaceuticals, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
JP6403219B2
(ja)
|
2012-12-07 |
2018-10-10 |
ベナトルクス ファーマシューティカルズ，インク． |
ベータ−ラクタマーゼ阻害剤
|
|
WO2014107535A1
(en)
|
2013-01-04 |
2014-07-10 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9101638B2
(en)
|
2013-01-04 |
2015-08-11 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9132140B2
(en)
*
|
2013-01-04 |
2015-09-15 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9241947B2
(en)
*
|
2013-01-04 |
2016-01-26 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9403850B2
(en)
|
2013-01-10 |
2016-08-02 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
SG11201506875YA
(en)
|
2013-03-15 |
2015-09-29 |
Intrexon Corp |
Boron-containing diacylhydrazines
|
|
US9687497B1
(en)
|
2014-05-05 |
2017-06-27 |
Rempex Pharmaceuticals, Inc. |
Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
HRP20191932T1
(hr)
|
2014-05-05 |
2020-01-24 |
Rempex Pharmaceuticals, Inc. |
Sinteza boronatnih soli i njihove uporabe
|
|
EP3145936B1
(en)
|
2014-05-19 |
2020-09-30 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
US9511142B2
(en)
|
2014-06-11 |
2016-12-06 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
CA2950917C
(en)
|
2014-06-11 |
2022-08-23 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
US10206937B2
(en)
*
|
2014-07-01 |
2019-02-19 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016065282A1
(en)
|
2014-10-24 |
2016-04-28 |
The Regents Of The University Of Michigan |
Nasal formulation, nasal kit, and method for enhancing nasal nitric oxide (no) levels
|
|
US10662205B2
(en)
|
2014-11-18 |
2020-05-26 |
Qpex Biopharma, Inc. |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
|
WO2016116892A1
(en)
|
2015-01-24 |
2016-07-28 |
Wockhardt Limited |
Antibacterial compositions
|
|
US20180051041A1
(en)
|
2015-03-17 |
2018-02-22 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
EP3285776B1
(en)
|
2015-04-24 |
2022-12-21 |
Melinta Therapeutics, Inc. |
Dosage regimen of vaborbactam and meropenem for treating bacterial infections in subjects with reduced renal function
|
|
WO2017100537A1
(en)
|
2015-12-10 |
2017-06-15 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
CA3026582A1
(en)
|
2016-06-30 |
2018-01-04 |
Qpex Biopharma, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
AU2017295866A1
(en)
|
2016-07-14 |
2019-01-17 |
Achaogen, Inc. |
Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
|
|
PT3512851T
(pt)
|
2016-09-16 |
2022-10-11 |
Entasis Therapeutics Ltd |
Compostos inibidores de beta-lactamase
|
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
|
KR102626967B1
(ko)
|
2017-10-11 |
2024-01-18 |
큐펙스 바이오파마 인코포레이티드 |
보론산 유도체 및 이의 합성
|
|
WO2019093450A1
(ja)
|
2017-11-10 |
2019-05-16 |
塩野義製薬株式会社 |
ジアザビシクロオクタン誘導体
|
|
WO2019204419A1
(en)
*
|
2018-04-20 |
2019-10-24 |
The Medicines Company (San Diego), Llc |
Boronic acid derivatives and therapeutic uses thereof
|
|
SG11202105505TA
(en)
|
2018-11-29 |
2021-06-29 |
Venatorx Pharmaceuticals Inc |
Combination compositions comprising a beta-lactamase inhibitor and uses thereof
|
|
HUE072159T2
(hu)
|
2019-06-19 |
2025-10-28 |
Qpex Biopharma Inc |
Bórsav-származékok és terápiás alkalmazásuk
|
|
JP7673052B2
(ja)
|
2019-08-29 |
2025-05-08 |
アリクサ ファーマシューティカルズ、インコーポレイテッド |
細菌感染症を処置するためのベータラクタム抗生物質およびアビバクタム誘導体の経口投与される組合せ
|